Ken Kudura

St. Claraspital Basel
Basel, BS 4058, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Divergent Prognostic Value of Primary Tumor Segmentation Metrics on Baseline FDG PET/CT in Colorectal Cancer.

Divergent Prognostic Value of Primary Tumor Segmentation Metrics on Baseline FDG PET/CT in Colorectal Cancer.

Journal: Cancers
Published: September 21, 2025

Tumor Segmentation on PSMA PET/CT Predicts Survival in Biochemical Recurrence of Prostate Cancer: A Retrospective Study Using [68Ga]Ga-PSMA-11 and [18F]-PSMA-1007.

Tumor Segmentation on PSMA PET/CT Predicts Survival in Biochemical Recurrence of Prostate Cancer: A Retrospective Study Using [68Ga]Ga-PSMA-11 and [18F]-PSMA-1007.

Journal: Cancers
Published: May 08, 2025

Diagnostic accuracy and treatment benefit of PET/CT in staging of colorectal cancer compared to conventional imaging.

Diagnostic accuracy and treatment benefit of PET/CT in staging of colorectal cancer compared to conventional imaging.

Journal: Surgical oncology
Published: April 10, 2024

An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.

An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.

Journal: Cancers
Published: October 31, 2023

Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed.

Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed.

Journal: Cancers
Published: May 19, 2023

Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.

Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.

Journal: Journal of clinical medicine
Published: March 29, 2023

Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.

Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.

Journal: Cancers
Published: January 12, 2023

Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.

Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.

Journal: Cancers
Published: November 08, 2022

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an 18F-FDG PET/CT after COVID-19 Vaccination.

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an 18F-FDG PET/CT after COVID-19 Vaccination.

Journal: Diagnostics (Basel, Switzerland)
Published: October 23, 2022

Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.

Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.

Journal: Cancers
Published: September 27, 2022

Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients.

Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients.

Journal: Biomedicines
Published: July 15, 2022

Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?

Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?

Journal: Life (Basel, Switzerland)
Published: July 08, 2022
Showing 1-12 of 40

Last Updated: 09/26/2026